Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 26, 1997 - Issue 3
38
Views
24
CrossRef citations to date
0
Altmetric
Original Article

An RGD Containing peptide from HIV-1 TAT-(65–80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549

, , , &
Pages 351-370 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Choua Thao, Andrew F. Shorr & Christian Woods. (2017) Non-infectious pulmonary disorders in HIV. Expert Review of Respiratory Medicine 11:3, pages 209-220.
Read now

Articles from other publishers (23)

Joseph Baruch Baluku, Naghib Bogere, Sharon Namiiro, Victoria Walusansa, Irene Andia-Biraro, William Worodria & Bruce Kirenga. (2022) HIV-related lung cancer in Uganda: a cohort study. Infectious Agents and Cancer 17:1.
Crossref
Neus Basté Rotllan. (2022) Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer. Cancer Medicine 11:S1, pages 10-16.
Crossref
Rachel M. Presti, Sonia C. Flores, Brent E. Palmer, Jeffrey J. Atkinson, Catherine R. Lesko, Bryan Lau, Andrew P. Fontenot, Jesse Roman, John F. McDyer & Homer L. TwiggIIIIII. (2017) Mechanisms Underlying HIV-Associated Noninfectious Lung Disease. Chest 152:5, pages 1053-1060.
Crossref
Nahid Akhtar & Jeena Gupta Bansal. (2017) Risk factors of Lung Cancer in nonsmoker. Current Problems in Cancer 41:5, pages 328-339.
Crossref
Til R. Kiderlen, Jan Siehl & Marcus Hentrich. (2017) HIV-Associated Lung Cancer. Oncology Research and Treatment 40:3, pages 88-92.
Crossref
Emanuela Vaccher, Diego Serraino, Antonino Carbone & Paolo De Paoli. (2014) The Evolving Scenario of Non-AIDS-Defining Cancers: Challenges and Opportunities of Care. The Oncologist 19:8, pages 860-867.
Crossref
Deepthi Mani & David M. Aboulafia. 2014. Cancers in People with HIV and AIDS. Cancers in People with HIV and AIDS 301 311 .
Tiffany A. Winstone, S.F. Paul Man, Mark Hull, Julio S. Montaner & Don D. Sin. (2013) Epidemic of Lung Cancer in Patients With HIV Infection. Chest 143:2, pages 305-314.
Crossref
Miriam Estébanez-Muñoz, Clara I. Soto-Abánades, Juan J. Ríos-Blanco & Jose R. Arribas. (2012) Actualización en la patología pulmonar relacionada con la infección VIH. Archivos de Bronconeumología 48:4, pages 126-132.
Crossref
Miriam Estébanez-Muñoz, Clara I. Soto-Abánades, Juan J. Ríos-Blanco & Jose R. Arribas. (2012) Updating Our Understanding of Pulmonary Disease Associated With HIV Infection. Archivos de Bronconeumología (English Edition) 48:4, pages 126-132.
Crossref
Deepthi Mani, Missak HaigentzJrJr & David M. Aboulafia. (2012) Lung Cancer in HIV Infection. Clinical Lung Cancer 13:1, pages 6-13.
Crossref
Charles S. Dela Cruz, Lynn T. Tanoue & Richard A. Matthay. (2011) Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine 32:4, pages 605-644.
Crossref
Irene Guendel, Lawrence Carpio, Rebecca Easley, Rachel Van Duyne, William Coley, Emmanuel Agbottah, Cynthia Dowd, Fatah Kashanchi & Kylene Kehn-Hall. (2009) 9-aminoacridine Inhibition of HIV-1 Tat Dependent Transcription. Virology Journal 6:1.
Crossref
Tristan Ferry, François Raffi, Fidéline Collin-Filleul, Michel Dupon, Pierre Dellamonica, Anne Waldner, Christophe Strady, Geneviève Chêne, Catherine Leport & Vincent Le Moing. (2009) Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:4, pages 407-415.
Crossref
Weilin Wu, Kylene Kehn-Hall, Caitlin Pedati, Lynnsey Zweier, Iris Castro, Zachary Klase, Cynthia S Dowd, Larisa Dubrovsky, Michael Bukrinsky & Fatah Kashanchi. (2008) Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation. Virology Journal 5:1.
Crossref
Ronen Gabizon, Michal Mor, Masha M. Rosenberg, Lena Britan, Zvi Hayouka, Moshe Kotler, Deborah E. Shalev & Assaf Friedler. (2008) Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 tat. Biopolymers 90:2, pages 105-116.
Crossref
G. D. Kirk, C. Merlo, P. O'Driscoll, S. H. Mehta, N. Galai, D. Vlahov, J. Samet & E. A. Engels. (2007) HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking. Clinical Infectious Diseases 45:1, pages 103-110.
Crossref
F. Bonnet & P. Morlat. (2006) Cancers et infection par le VIH : quelles associations ?. La Revue de Médecine Interne 27:3, pages 227-235.
Crossref
Armelle Lavolé, Marie Wislez, Martine Antoine, Charles Mayaud, Bernard Milleron & Jacques Cadranel. (2006) Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 51:1, pages 1-11.
Crossref
Alina Burgi, Stephanie Brodine, Scott Wegner, Mark Milazzo, Mark R. Wallace, Katherine Spooner, David L. Blazes, Brian K. Agan, Adam Armstrong, Susan Fraser & Nancy F. Crum. (2005) Incidence and risk factors for the occurrence of non‐AIDS‐defining cancers among human immunodeficiency virus‐infected individuals. Cancer 104:7, pages 1505-1511.
Crossref
Fabrice Bonnet, Charlotte Lewden, Thierry May, Laurence Heripret, Eric Jougla, Sibylle Bevilacqua, Dominique Costagliola, Dominique Salmon, Geneviève Chêne & Philippe Morlat. (2004) Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy. Cancer 101:2, pages 317-324.
Crossref
M. Rusnati, G. Taraboletti, C. Urbinati, G. Tulipano, R. Giuliani, M. P. Molinari-Tosatti, B. Sennino, M. Giacca, M. Tyagi, A. Albini, D. Noonan, R Giavazzi & M. Presta. (2000) Thrombospondin‐1/HIV‐1 Tat protein interaction: modulation of the biological activity of extracellular Tat. The FASEB Journal 14:13, pages 1917-1930.
Crossref
Elizabeth Clark, Francisco Santiago, Longwen Deng, Siew yen Chong, Cynthia de la Fuente, Lai Wang, Peng Fu, Dana SteinThomas DennyVenkata Lanka, Fariba Mozafari, Takashi Okamoto & Fatah Kashanchi. (2000) Loss of G 1 /S Checkpoint in Human Immunodeficiency Virus Type 1-Infected Cells Is Associated with a Lack of Cyclin-Dependent Kinase Inhibitor p21/Waf1 . Journal of Virology 74:11, pages 5040-5052.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.